While specific mutations (such as SERPINB2) might contribute to tumor biology in individual cases, it is also conceivable that most of the identified mutations represent passenger mutations that do not have functional effects in pancreatic cancer-associated PSCs. The gene discussed is SERPINB2; the disease is pancreatic neoplasm.